Startups

Organ Health Specialist

Natera · Sacramento, CA · On-site

← All jobs
About Natera

Dedicated to oncology, women’s health, and organ health. Natera’s cell-free DNA tests help protect health and inform more personalized decisions about care. Backed by Lightspeed and Sequoia.

About the role

As an Organ Health Specialist , you will promote and sell Renasight , a genetic test analyzing 385 genes to identify potential hereditary causes of kidney disease, and Prospera , a non-invasive cfDNA test for early detection of kidney transplant rejection—both supporting comprehensive kidney health management from diagnosis to post-transplant care. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Bachelor’s Degree or equivalent educational background
  • A minimum of 3-5 years of progressive sales experience, ideally within laboratory, molecular, or diagnostic sales
  • Proven track record of closing sales, building client relationships, and driving revenue growth
  • Proven ability to drive adoption through clinical education and consultative selling
  • Existing relationships with key opinion leaders (KOLs) in nephrology or specialty medicine
  • Knowledge of academic medical systems and large hospital systems (IDNs) related to nephrology or specialty medicine
More about this role

TERRITORY: Northern California (Sacramento to Eureka and Redding) and Northern Nevada (Reno, Carson City, and surrounding communities).

We are looking for an Organ Health Specialist (OHS) to join the Organ Health sales team! In this role, you will drive growth and market development within the general nephrology market by cultivating new and maintaining existing key relationships, executing strategic business plans, and promoting the adoption of Organ Health products. Your expertise and insights will play a critical role in advancing our mission to support healthcare providers with innovative diagnostic tools.

As an Organ Health Specialist , you will promote and sell Renasight , a genetic test analyzing 385 genes to identify potential hereditary causes of kidney disease, and Prospera , a non-invasive cfDNA test for early detection of kidney transplant rejection—both supporting comprehensive kidney health management from diagnosis to post-transplant care.

  • Achieve and exceed performance goals through effective sales strategies, client relationship building, and territory management.
  • Drive market adoption of Natera’s Organ Health portfolio (Renasight and Prospera), contributing...

Read the full posting on Natera's site ↗

Organ Health Sales - Abdominal

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.